Alzheimer disease as a clinical-biological construct—an International Working Group recommendation

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024 - jamanetwork.com
Importance Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer's …
被引用次数：26 相关文章

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024 - cdr.lib.unc.edu
Importance: Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer …

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024 - mayoclinic.elsevierpure.com
Importance: Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer's …

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024 - cnrs.hal.science
Importance Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer …

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

B Dubois, N Villain, L Schneider, NC Fox, N Campbell… - 2024 - repositorio.fleni.org.ar
Importance: Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer …
[HTML] regionh.dk

[HTML][HTML] Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024 - research.regionh.dk
IMPORTANCE: Since 2018, a movement has emerged to define Alzheimer disease (AD) as
a purely biological entity based on biomarker findings. The recent revision of the Alzheimer's …

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation.

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024 - search.ebscohost.com
Abstract This Special Communication discusses a recent revision of the Alzheimer's
Association (AA) criteria to define Alzheimer disease (AD) as a purely biological entity …

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024 - discovery.ucl.ac.uk
Importance: Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer …

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024 - pubmed.ncbi.nlm.nih.gov
Importance Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer's …

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024 - dial.uclouvain.be
Importance: Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer's …